Description
Composition- Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg SR
Mode of Action- Combines incretin enhancement, insulin sensitization and reduced hepatic glucose production for comprehensive multi-pathway glycemic control.
USPs- Triple oral antidiabetic support; useful in uncontrolled type 2 diabetes; sustained metformin benefit improves stability.
Prescribing Specialties- Diabetologist, Internal Medicine, General Physician
